
TY  - JOUR
AU  - Anguita, M.
AU  - Castillo, J.C.
AU  - Montes, P.
AU  - Martinez, A.
AU  - On behalf of NT-proBNP-IC Spanish Multicentric Study
TI  - 446 Utility of NT-proBNP for the diagnosis of heart failure in an heterogeneous population of patients with dyspnea. A Spanish mutlicentric study
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 5
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1016/S1567-4215(06)80308-5
DO  - doi:10.1016/S1567-4215(06)80308-5
SP  - 107
EP  - 107
PY  - 2006
ER  - 

TY  - JOUR
AU  - Shah, Keyur B.
AU  - Kop, Willem J.
AU  - Christenson, Robert H.
AU  - Diercks, Deborah B.
AU  - Kuo, Dick
AU  - Henderson, Sue
AU  - Hanson, Karen
AU  - Li, Shu-Ying
AU  - deFilippi, Christopher R.
TI  - Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 11
IS  - 7
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hfp075
DO  - doi:10.1093/eurjhf/hfp075
SP  - 659
EP  - 667
KW  - Heart failure
KW  - Natriuretic peptides
KW  - Echocardiography
KW  - Prognosis
PY  - 2009
AB  - Aims Previous evaluations of natriuretic peptide (NP) levels in patients with acute dyspnoea presenting to the emergency department (ED) have selected only a minority of patients for echocardiography. We aimed to evaluate the association between NPs and more subtle echocardiographic findings and to assess the potential for NPs to provide additional prognostic information beyond that provided by echocardiography in ?all-comers? with acute dyspnoea. Methods and results Prospective echocardiograms were performed on 338/412 patients presenting to the ED with acute dyspnoea. B-type natriuretic peptide and NT-proBNP were measured on presentation. Patients were followed-up for 1 year. Decompensated heart failure was diagnosed in 37% of patients and 13% died. The diagnostic accuracy (c-statistic) of BNP and NT-proBNP for identifying LVEF ≤ 40% was 0.88 (P < 0.001) and 0.86 (P < 0.001), respectively. The c-statistics for BNP and NT-proBNP for identifying diastolic dysfunction were 0.67 (P < 0.001) and 0.67 (P < 0.001); but only 0.57 (P = 0.09) and 0.60 (P = 0.02) in patients with LVEF ≥ 50%. Natriuretic peptides, but not LV mass or diastolic parameters, independently predicted mortality at 1 year in all patients and in those with an LVEF ≥ 50%. Conclusion In an acute dyspnoea population with ?all-comers? undergoing echocardiography, NPs correlate strongly with structural abnormalities and identify those with preserved LVEF at highest risk for death. Careful interpretation of elevated NP values is needed in the presence of preserved systolic function.
ER  - 

TY  - JOUR
AU  - Potocki, M.
AU  - Breidthardt, T.
AU  - Reichlin, T.
AU  - Hartwiger, S.
AU  - Morgenthaler, N. G.
AU  - Bergmann, A.
AU  - Noveanu, M.
AU  - Freidank, H.
AU  - Taegtmeyer, A. B.
AU  - Wetzel, K.
AU  - Boldanova, T.
AU  - Stelzig, C.
AU  - Bingisser, R.
AU  - Christ, M.
AU  - Mueller, C.
TI  - Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic   peptide in the diagnosis of heart failure
JO  - Journal of Internal Medicine
VL  - 267
IS  - 1
SN  - 0954-6820
UR  - https://doi.org/10.1111/j.1365-2796.2009.02135.x
DO  - doi:10.1111/j.1365-2796.2009.02135.x
SP  - 119
EP  - 129
KW  - dyspnoea
KW  - emergency diagnosis
KW  - heart failure
KW  - MRproANP
KW  - natriuretic peptides
PY  - 2010
AB  - Abstract. Objectives.? The concentration of atrial natriuretic peptide (ANP) in the circulation is approximately 10- to 50- fold higher than B-type natriuretic peptide (BNP). We sought to compare the accuracy of midregional pro-atrial natriuretic peptide (MRproANP) measured with a novel sandwich immunoassay with N-terminal pro-B-type natriuretic peptide (NTproBNP) in the diagnosis of heart failure. Design.? The diagnosis of heart failure was adjudicated by two independent cardiologists using all available clinical data (including BNP levels) in 287 consecutive patients presenting with dyspnoea to the emergency department (ED). MRproANP and NTproBNP levels were determined at presentation in a blinded fashion. Results.? Heart failure was the adjudicated final diagnosis in 154 patients (54%). Median MRproANP was significantly higher in patients with heart failure as compared to patients with other causes of dyspnoea (400 vs. 92?pmol?L?1, P?<?0.001). The diagnostic accuracy of MRproANP was very high with an area under the receiver operating characteristic curve of 0.92 and was comparable with that of NTproBNP (0.92, P?=?0.791). Moreover, MRproANP provided incremental diagnostic information to BNP and NTproBNP in patients presenting with BNP levels in the grey zone between 100 and 500?pg?mL?1. Conclusion.? Midregional pro-atrial natriuretic peptide is as accurate in the diagnosis of heart failure as NTproBNP. MRproANP seems to provide incremental information on top of BNP or NT-proBNP in some subgroups and should be further investigated in other studies.
ER  - 

TY  - JOUR
TI  - Poster Session 3
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr007
DO  - doi:10.1093/eurjhf/hsr007
SP  - S116
EP  - S161
PY  - 2011
ER  - 

TY  - JOUR
TI  - POSTER SESSION: CLINICAL
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 12
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hst009
DO  - doi:10.1093/eurjhf/hst009
SP  - S73
EP  - S325
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Session 4
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr009
DO  - doi:10.1093/eurjhf/hsr009
SP  - S166
EP  - S214
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session 4
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.93_21
DO  - doi:10.1002/ejhf.93_21
SP  - 317
EP  - 365
PY  - 2014
ER  - 

TY  - JOUR
AU  - Wechalekar, Ashutosh D.
AU  - Gillmore, Julian D.
AU  - Bird, Jenny
AU  - Cavenagh, Jamie
AU  - Hawkins, Stephen
AU  - Kazmi, Majid
AU  - Lachmann, Helen J.
AU  - Hawkins, Philip N.
AU  - Pratt, Guy
AU  - the BCSH Committee
TI  - Guidelines on the management of AL amyloidosis
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 168
IS  - 2
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.13155
DO  - doi:10.1111/bjh.13155
SP  - 186
EP  - 206
KW  - amyloid
KW  - AL amyloidosis
KW  - guidelines
KW  - chemotherapy
KW  - transplantation
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session 5
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr011
DO  - doi:10.1093/eurjhf/hsr011
SP  - S218
EP  - S263
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts Programme
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 21
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1488
DO  - doi:10.1002/ejhf.1488
SP  - 5
EP  - 592
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr005
DO  - doi:10.1093/eurjhf/hsr005
SP  - S60
EP  - S104
PY  - 2011
ER  - 

TY  - JOUR
AU  - Möckel, Martin
AU  - de Boer, Rudolf A.
AU  - Slagman, Anna Christine
AU  - von Haehling, Stephan
AU  - Schou, Morten
AU  - Vollert, Jörn Ole
AU  - Wiemer, Jan C.
AU  - Ebmeyer, Stefan
AU  - Martín-Sánchez, F. Javier
AU  - Maisel, Alan S.
AU  - Giannitsis, Evangelos
TI  - Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - n/a
IS  - n/a
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1667
DO  - doi:10.1002/ejhf.1667
KW  - Acute heart failure
KW  - Procalcitonin
KW  - Natriuretic peptides
KW  - Antibiotic therapy
KW  - Mortality
AB  - Aim To determine whether initiation of antibiotic therapy (ABX) by procalcitonin (PCT) within 8 h of admission in patients presenting to the emergency department with symptoms and signs of acute heart failure (AHF) and elevated natriuretic peptides would improve clinical outcomes. Methods and results The study was a randomized multicentre clinical trial conducted at 16 sites in Europe. Patients were randomized to either a PCT-guided strategy or standard care. Patients with PCT-guided strategy (n =?370) had ABX initiated if PCT was >?0.2 ?g/L. Patients with standard care (n =?372) had AHF care in accordance with published guidelines without PCT. The primary endpoint was 90-day all-cause mortality. Pre-specified secondary endpoints included 30-day all-cause mortality and readmission and rate of pneumonia. The Data Safety and Review Committee recommended stopping the study for futility when 762 of the planned 792 patients had been enrolled. A total of?742 patients could be analysed. Patients were elderly (median age: 77?years), 38% were women, and had typical signs and symptoms of AHF. All-cause mortality at 90?days was 10.3% in the PCT-guided group vs. 8.2% in standard care (P =?0.316). Thirty-day readmission was significantly higher in the PCT-guided group vs. standard care but the difference vanished until day 90. The rate of pneumonia was overall low (7.5%) and not different between groups. Conclusions In patients with AHF, a strategy of PCT-guided initiation of ABX was not more effective than a standard care strategy in improving clinical outcomes.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 20
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1197
DO  - doi:10.1002/ejhf.1197
SP  - 5
EP  - 638
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 18
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.539
DO  - doi:10.1002/ejhf.539
SP  - 8
EP  - 521
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 19
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.833
DO  - doi:10.1002/ejhf.833
SP  - 5
EP  - 601
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 17
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.277
DO  - doi:10.1002/ejhf.277
SP  - 5
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 11
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hss008
DO  - doi:10.1093/eurjhf/hss008
SP  - S67
EP  - S117
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Presentation
JO  - Cardiovascular Therapeutics
JA  - Cardiovasc Ther
VL  - 30
IS  - s1
SN  - 1755-5914
UR  - https://doi.org/10.1111/1755-5922.12011_3
DO  - doi:10.1111/1755-5922.12011_3
SP  - 64
EP  - 90
PY  - 2012
ER  - 

TY  - JOUR
TI  - European College of Veterinary Internal Medicine-Companion Animals
JO  - Journal of Veterinary Internal Medicine
VL  - 24
IS  - 6
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2010.0625.x
DO  - doi:10.1111/j.1939-1676.2010.0625.x
SP  - 1537
EP  - 1576
PY  - 2010
ER  - 

TY  - JOUR
AU  - Ponikowski, Piotr
AU  - Voors, Adriaan A.
AU  - Anker, Stefan D.
AU  - Bueno, Héctor
AU  - Cleland, John G. F.
AU  - Coats, Andrew J. S.
AU  - Falk, Volkmar
AU  - González-Juanatey, José Ramón
AU  - Harjola, Veli-Pekka
AU  - Jankowska, Ewa A.
AU  - Jessup, Mariell
AU  - Linde, Cecilia
AU  - Nihoyannopoulos, Petros
AU  - Parissis, John T.
AU  - Pieske, Burkert
AU  - Riley, Jillian P.
AU  - Rosano, Giuseppe M. C.
AU  - Ruilope, Luis M.
AU  - Ruschitzka, Frank
AU  - Rutten, Frans H.
AU  - van der Meer, Peter
AU  - Authors/Task Force Members
AU  - Document Reviewers
TI  - 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 18
IS  - 8
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.592
DO  - doi:10.1002/ejhf.592
SP  - 891
EP  - 975
KW  - Guidelines
KW  - Heart failure
KW  - Natriuretic peptides
KW  - Ejection fraction
KW  - Diagnosis
KW  - Pharmacotherapy
KW  - Neuro-hormonal antagonists
KW  - Cardiac resynchronization therapy
KW  - Mechanical circulatory support
KW  - Transplantation
KW  - Arrhythmias
KW  - Co-morbidities
KW  - Hospitalization
KW  - Multidisciplinary management
PY  - 2016
ER  - 
